Patents by Inventor Siddharth Pandey

Siddharth Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957815
    Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: April 16, 2024
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
  • Patent number: 11960477
    Abstract: Techniques are described herein for managing transactions between data consumers and data providers using a blockchain. In some embodiments, a blockchain network receive smart contracts that govern access rights to data sets provided by blockchain members and smart contracts that execute blockchain transactions based on the usage of data sets. When a data set is provided to a blockchain member through the blockchain network, usage of the data set may be tracked. Responsive to detecting usage of the data set, one or more smart contracts may execute one or more blockchain transactions within the blockchain network.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: April 16, 2024
    Assignee: Oracle International Corporation
    Inventors: Saurabh Pandey, Joseph Rice, Siddharth Gupta
  • Patent number: 11612631
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: March 28, 2023
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
  • Publication number: 20220016320
    Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.
    Type: Application
    Filed: November 12, 2020
    Publication date: January 20, 2022
    Inventors: Rajan DATT, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
  • Publication number: 20210346456
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Application
    Filed: June 8, 2021
    Publication date: November 11, 2021
    Inventors: Rajan DATT, SIDDHARTH PANDEY, PALLAVI SHRIVASTAVA, RAMADHAR KUMAR
  • Patent number: 11126670
    Abstract: A network device receives credentials of a user of a client device, and receives an enrollment request from the client device, wherein the enrollment request includes a network address of the client device. The network device generates a token comprising the network address and an identifier of the user, encrypts the token, and sends the encrypted token to the client device. The network device receives, when the client device attempts to access a protected resource or a network service, the encrypted token from the client device for authenticating the client device without further requiring the credentials of the user.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: September 21, 2021
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Siddharth Pandey, Manah M. Khalil, Michael R. Lamison, John J. Christudass, Krishna C. Yendrapalli, Narayanan Kasiviswanathan Shankar, Saikumar Dubagunta, Ping Chu, Maneesha Kalra
  • Patent number: 11058741
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phytopharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: July 13, 2021
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
  • Patent number: 10561701
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: February 18, 2020
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
  • Publication number: 20200038470
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phytopharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Inventors: Rajan DATT, SIDDHARTH PANDEY, PALLAVI SHRIVASTAVA, RAMADHAR KUMAR
  • Publication number: 20190167837
    Abstract: The invention relates to porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for controlling bleeding, wound closure, prevent tissue adhesion and/or support tissue regeneration. The invention provides a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foams, suitable for packing antrum or other cavities of the body, comprising of composite of polymers, which polymer preferably comprises —C(O)—O—; NH2/3+; —OH; —CH2OCH2C(O)O— groups as functional or —CH—O— (e.g. C2H4O; C6H10O5; C6H8O6); —CH—N—O— (e.g. C8H13NO5); O—C—C— (e.g. O-CH2-CH2); —C(O)N— groups in the backbone of the polymers e.g. gelatin, chitosan, collagen, alginate, polyvinyl alcohol, polyethylene glycol, keratin, cellulose.
    Type: Application
    Filed: February 5, 2019
    Publication date: June 6, 2019
    Inventors: Rajan DATT, RAMADHAR KUMAR, SIDDHARTH PANDEY, PALLAVI SHRIVASTAVA
  • Patent number: 10293075
    Abstract: The invention relates to porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for controlling bleeding, wound closure, prevent tissue adhesion and/or support tissue regeneration. The invention provides a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foams, suitable for packing antrum or other cavities of the body, comprising of composite of polymers, which polymer preferably comprises —C(O)—O—; NH2/3+; —OH; —CH2OCH2C(O)O— groups as functional or —CH—O— (e.g. C2H4O; C6H10O5; C6H8O6); —CH—N—O— (e.g. C8H13NO5); O—C—C— (e.g. O—CH2-CH2); —C(O)N— groups in the backbone of the polymers e.g. gelatin, chitosan, collagen, alginate, polyvinyl alcohol, polyethylene glycol, keratin, cellulose.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: May 21, 2019
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Ramadhar Kumar, Siddharth Pandey, Pallavi Shrivastava
  • Publication number: 20180369315
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
  • Publication number: 20180353655
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 13, 2018
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
  • Patent number: 10149924
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: December 11, 2018
    Assignees: DATT MEDIPRODUCTS LIMITED, DATT LIFE SCIENCE PVT. LTD.
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
  • Publication number: 20180332016
    Abstract: A network device receives credentials of a user of a client device, and receives an enrollment request from the client device, wherein the enrollment request includes a network address of the client device. The network device generates a token comprising the network address and an identifier of the user, encrypts the token, and sends the encrypted token to the client device. The network device receives, when the client device attempts to access a protected resource or a network service, the encrypted token from the client device for authenticating the client device without further requiring the credentials of the user.
    Type: Application
    Filed: May 10, 2017
    Publication date: November 15, 2018
    Inventors: Siddharth Pandey, Manah M. Khalil, Michael R. Lamison, John J. Christudass, Krishna C. Yendrapalli, Narayanan Kasiviswanathan Shankar, Saikumar Dubagunta, Ping Chu, Maneesha Kalra
  • Patent number: 10098986
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: October 16, 2018
    Assignees: DATT MEDIPRODUCTS LIMITED, DATT LIFE SCIENCE PVT. LTD.
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
  • Publication number: 20180289865
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 11, 2018
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
  • Patent number: 10076552
    Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: September 18, 2018
    Assignee: DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD.
    Inventors: Rajan Datt, Ramadhar Kumar, Siddharth Pandey, Pallavi Shrivastava
  • Patent number: 10021673
    Abstract: A wireless communication device (UE) conducting wireless communications according to a specified radio access technology (RAT) in a first communications band belonging to a first network may be required to switch to a different communications band due to network restrictions and/or radio link failure. The UE may therefore perform a system scan identifying other communications bands associated with the first RAT and available at the present location of the UE. The UE may identify whether the other communications bands include preferred communications bands belonging to the first network, support a service associated with the wireless communications of the UE, and have an energy level higher than a specified threshold. If one or more preferred communications bands are present, the UE may switch communications from the first communications band to one of the preferred communications bands, even if it doesn't have the highest energy level among all the other communications bands.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: July 10, 2018
    Assignee: Apple Inc.
    Inventors: Alosious Pradeep Prabhakar, Jose A. Castelo Vega, Siddharth Pandey, Aditya A. Marawar, Rafael L. Rivera-Barreto
  • Patent number: 10004830
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: June 26, 2018
    Assignee: DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD.
    Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava